H-Immune Therapeutics - Ownership and Business Overview

Life ScienceCompany

H-Immune Therapeutics Ownership

Who owns H-Immune Therapeutics?

H-Immune Therapeutics is owned by HiFiBiO Therapeutics. It was acquired on October 15, 2018.

H-Immune Therapeutics Business Overview

Where is H-Immune Therapeutics headquartered?

H-Immune Therapeutics is headquartered in Paris, France.

What sector is H-Immune Therapeutics in?

H-Immune Therapeutics is a life science company.

When was H-Immune Therapeutics founded?

H-Immune Therapeutics was founded in 2016.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

H-Immune Therapeutics

Paris,
France,
www.h-immune.com

H-Immune Therapeutics is an early-stage biotechnology company engaged in the discovery and development of novel immuno-oncology therapeutics.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for H-Immune Therapeutics

Life Science Companies , France Companies